MDL

Other

Medline, Inc. ·Balance Sheet Statement·64 metrics

Breakdown

Loading...

Metrics

Other taxes payable

Customer rebates and distributor chargebacks

Allowance for doubtful accounts

Business Combination, Contingent Consideration, Liability

Short-term debt and current portion of long-term debt

Long-term debt, gross

Debt Issuance Costs, Net

Deferred tax asset, tax receivable agreement

Notional amount, annual incremental decrease

Cost not yet recognized

Estimated excess of current replacement cost over LIFO cost of inventories

Thereafter

Finite-Lived Intangible Assets, Accumulated Amortization

2028

2030

Remainder of 2026

2027

2029

Gross Carrying Amount

Indefinite- lived intangible impairment

Limited Partners Capital Account

2028

2029

2030

2027

Remainder of 2026

Noncontrolling interests in subsidiaries

Long-Lived Assets

Number of classes

Number of third-party suppliers

Other accrued liabilities

Partners Capital

Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Shares Authorized

Preferred Stock, Shares Issued

Preferred Stock, Shares Outstanding

Recorded Unconditional Purchase Obligation

2024

2025

2026

Recorded Unconditional Purchase Obligation, Due in Remainder of Fiscal Year

2023

Thereafter

Sale of stock, price per share (in dollars per share)

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

Expected to vest (in dollars per share)

Exercisable (in dollars per share)

Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price

Tax receivable agreement liability

Tax receivable agreement liability, current

Tax receivable agreement liability

Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2025

Unrecorded Unconditional Purchase Obligation

Unrecorded Unconditional Purchase Obligation - Due Year Two

Unrecorded Unconditional Purchase Obligation - Due Year Three

Unrecorded Unconditional Purchase Obligation - Due Year Four